المؤلفون: Le AD, Alzghari SK, Jean GW, La-Beck NM

المصدر: Therapeutics and Clinical Risk Management, Vol Volume 13, Pp 223-236 (2017)

مصطلحات موضوعية: nivolumab, lung cancer, immune checkpoint, targeted therapy, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: https://www.dovepress.com/update-on-targeted-therapies-for-advanced-non-small-cell-lung-cancer-n-peer-reviewed-article-TCRM; https://doaj.org/toc/1178-203X

URL الوصول: https://doaj.org/article/bf14c95038f44d1ba47d3ecd604cf780

المؤلفون: La-Beck NM, Zamboni BA, Gabizon A, Schmeeda H, Amantea M, Gehrig PA, Zamboni WC

المصدر: Cancer Chemotherapy & Pharmacology; Jan2012, Vol. 69 Issue 1, p43-50, 8p

المؤلفون: Anchordoquy T; Department of Pharmaceutical Sciences, The Skaggs School of Pharmacy and Pharmaceutical Sciences, the University of Colorado Anschutz Medical Campus, Aurora, Colorado 80045, United States., Artzi N; Brigham and Woman's Hospital, Department of Medicine, Division of Engineering in Medicine, Harvard Medical School, Boston, Massachusetts 02215, United States.; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts 02215, United States.; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts 02215, United States., Balyasnikova IV; Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University; Northwestern Medicine Malnati Brain Tumor Institute of the Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, United States., Barenholz Y; Membrane and Liposome Research Lab, IMRIC, Hebrew University Hadassah Medical School, Jerusalem 9112102, Israel., La-Beck NM; Department of Immunotherapeutics and Biotechnology, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, Texas 79601, United States., Brenner JS; Departments of Medicine and Pharmacology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States., Chan WCW; Institute of Biomedical Engineering, University of Toronto, Rosebrugh Building, 164 College Street, Toronto, Ontario M5S 3G9, Canada.; Terrence Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, 160 College Street, Toronto, Ontario M5S 3E1, Canada., Decuzzi P; Laboratory of Nanotechnology for Precision Medicine, Italian Institute of Technology, 16163 Genova, Italy., Exner AA; Departments of Radiology and Biomedical Engineering, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, United States., Gabizon A; The Helmsley Cancer Center, Shaare Zedek Medical Center and The Hebrew University of Jerusalem-Faculty of Medicine, Jerusalem, 9103102, Israel., Godin B; Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas 77030, United States.; Department of Obstetrics and Gynecology, Houston Methodist Hospital, Houston, Texas 77030, United States.; Department of Obstetrics and Gynecology, Weill Cornell Medicine College (WCMC), New York, New York 10065, United States.; Department of Biomedical Engineering, Texas A&M, College Station, Texas 7784,3 United States., Lai SK; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina 27599, United States., Lammers T; Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, Center for Biohybrid Medical Systems, University Hospital RWTH Aachen, 52074 Aachen, Germany., Mitchell MJ; Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.; Penn Institute for RNA Innovation, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States., Moghimi SM; School of Pharmacy, Newcastle University, Newcastle upon Tyne NE1 7RU, U.K.; Translational and Clinical Research Institute, Faculty of Health and Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, U.K.; Colorado Center for Nanomedicine and Nanosafety, University of Colorado Anschutz Medical Center, Aurora, Colorado 80045, United States., Muzykantov VR; Department of Systems Pharmacology and Translational Therapeutics, The Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States., Peer D; Laboratory of Precision Nanomedicine, Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, 69978, Israel.; Department of Materials Sciences and Engineering, Iby and Aladar Fleischman Faculty of Engineering, Tel Aviv University, Tel Aviv, 69978, Israel.; Center for Nanoscience and Nanotechnology, Tel Aviv University, Tel Aviv, 69978, Israel.; Cancer Biology Research Center, Tel Aviv University, Tel Aviv, 69978, Israel., Nguyen J; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina 27599, United States., Popovtzer R; Faculty of Engineering and the Institute of Nanotechnology & Advanced Materials, Bar-Ilan University, 5290002 Ramat Gan, Israel., Ricco M; Department of Pharmaceutical Sciences, The Skaggs School of Pharmacy and Pharmaceutical Sciences, the University of Colorado Anschutz Medical Campus, Aurora, Colorado 80045, United States., Serkova NJ; Department of Radiology, University of Colorado Cancer Center, Anschutz Medical Campus, Aurora, Colorado 80045, United States., Singh R; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27101, United States.; Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina 27101, United States., Schroeder A; Department of Chemical Engineering, Technion, Israel Institute of Technology, Haifa 32000, Israel., Schwendeman AA; Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48108; Biointerfaces Institute, University of Michigan, Ann Arbor, Michigan 48108, United States., Straehla JP; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts 02115 United States.; Koch Institute for Integrative Cancer Research at MIT, Cambridge Massachusetts 02139 United States., Teesalu T; Laboratory of Precision and Nanomedicine, Institute of Biomedicine and Translational Medicine, University of Tartu, 50411 Tartu, Estonia., Tilden S; Department of Pharmaceutical Sciences, The Skaggs School of Pharmacy and Pharmaceutical Sciences, the University of Colorado Anschutz Medical Campus, Aurora, Colorado 80045, United States., Simberg D; Department of Pharmaceutical Sciences, The Skaggs School of Pharmacy and Pharmaceutical Sciences, the University of Colorado Anschutz Medical Campus, Aurora, Colorado 80045, United States.

المصدر: ACS nano [ACS Nano] 2024 Jun 04; Vol. 18 (22), pp. 13983-13999. Date of Electronic Publication: 2024 May 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101313589 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1936-086X (Electronic) Linking ISSN: 19360851 NLM ISO Abbreviation: ACS Nano Subsets: MEDLINE

مواضيع طبية MeSH: Nanomedicine*, Humans ; Drug Carriers/chemistry ; Liposomes/chemistry ; Nanoparticles/chemistry ; United States

المؤلفون: La-Beck NM; Department of Immunotherapeutics and Biotechnology, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, USA.; Center of Excellence in Real-World Evidence, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Dallas, USA., Lee YR; Ben and Maytee Fisch College of Pharmacy, University of Texas at Tyler, Tyler, USA., Patel J; Department of Immunotherapeutics and Biotechnology, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, USA., Yang H; Department of Pharmacy Practice, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Dallas, USA.; Center of Excellence in Real-World Evidence, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Dallas, USA., Stout M; Ben and Maytee Fisch College of Pharmacy, University of Texas at Tyler, Tyler, USA., Kologey A; Ben and Maytee Fisch College of Pharmacy, University of Texas at Tyler, Tyler, USA., Ruesewald A; Ben and Maytee Fisch College of Pharmacy, University of Texas at Tyler, Tyler, USA., Alvarez CA; Department of Pharmacy Practice, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Dallas, USA.; Center of Excellence in Real-World Evidence, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Dallas, USA.

المصدر: Cureus [Cureus] 2024 Jun 03; Vol. 16 (6), pp. e61600. Date of Electronic Publication: 2024 Jun 03 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE

المؤلفون: Gabizon A; Nano-Oncology Research Center, Oncology Institute, Shaare Zedek Medical Center, Jerusalem 9103102, Israel.; Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel., Shmeeda H; Nano-Oncology Research Center, Oncology Institute, Shaare Zedek Medical Center, Jerusalem 9103102, Israel., Draper B; King's College London, School of Cancer and Pharmaceutical Sciences, Guy's Cancer Centre, Great Maze Pond, London SE1 9RT, UK., Parente-Pereira A; King's College London, School of Cancer and Pharmaceutical Sciences, Guy's Cancer Centre, Great Maze Pond, London SE1 9RT, UK., Maher J; King's College London, School of Cancer and Pharmaceutical Sciences, Guy's Cancer Centre, Great Maze Pond, London SE1 9RT, UK., Carrascal-Miniño A; King's College London, School of Biomedical Engineering & Imaging Sciences, St. Thomas' Hospital, London SE1 7EH, UK., de Rosales RTM; King's College London, School of Biomedical Engineering & Imaging Sciences, St. Thomas' Hospital, London SE1 7EH, UK., La-Beck NM; Department of Immunotherapeutics and Biotechnology, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, TX 79601, USA.

المصدر: Pharmaceutics [Pharmaceutics] 2023 Nov 09; Vol. 15 (11). Date of Electronic Publication: 2023 Nov 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101534003 Publication Model: Electronic Cited Medium: Print ISSN: 1999-4923 (Print) Linking ISSN: 19994923 NLM ISO Abbreviation: Pharmaceutics Subsets: PubMed not MEDLINE

المؤلفون: Islam MR; Department of Immunotherapeutics and Biotechnology, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, TX 79601, USA., Patel J; Department of Immunotherapeutics and Biotechnology, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, TX 79601, USA., Back PI; Department of Immunotherapeutics and Biotechnology, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, TX 79601, USA., Shmeeda H; Nano-Oncology Research Center, Oncology Institute, Shaare Zedek Medical Center, Jerusalem 9103102, Israel., Kallem RR; Department of Pharmacy Practice, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, TX 79601, USA.; Clinical Pharmacology and Experimental Therapeutics Center, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Dallas, TX 75235, USA., Shudde C; Department of Immunotherapeutics and Biotechnology, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, TX 79601, USA., Markiewski M; Department of Immunotherapeutics and Biotechnology, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, TX 79601, USA., Putnam WC; Department of Pharmacy Practice, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, TX 79601, USA.; Clinical Pharmacology and Experimental Therapeutics Center, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Dallas, TX 75235, USA.; Department of Pharmaceutical Science, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Dallas, TX 75235, USA., Gabizon AA; Nano-Oncology Research Center, Oncology Institute, Shaare Zedek Medical Center, Jerusalem 9103102, Israel.; Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel., La-Beck NM; Department of Immunotherapeutics and Biotechnology, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, TX 79601, USA.; Department of Pharmacy Practice, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, TX 79601, USA.

المصدر: Biomolecules [Biomolecules] 2023 Aug 26; Vol. 13 (9). Date of Electronic Publication: 2023 Aug 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101596414 Publication Model: Electronic Cited Medium: Internet ISSN: 2218-273X (Electronic) Linking ISSN: 2218273X NLM ISO Abbreviation: Biomolecules Subsets: MEDLINE

المؤلفون: Islam MR; Department of Immunotherapeutics and Biotechnology, Texas Tech University Health Sciences Center School of Pharmacy, Abilene, TX, USA., Patel J; Department of Immunotherapeutics and Biotechnology, Texas Tech University Health Sciences Center School of Pharmacy, Abilene, TX, USA., Back PI; Department of Immunotherapeutics and Biotechnology, Texas Tech University Health Sciences Center School of Pharmacy, Abilene, TX, USA., Shmeeda H; Oncology Institute, Shaare Zedek Medical Center and Hebrew University-Faculty of Medicine, Jerusalem, Israel., Adamsky K; Levco Pharmaceuticals Ltd., Jerusalem, Israel., Yang H; Department of Pharmacy Practice, Texas Tech University Health Sciences Center School of Pharmacy, Abilene, TX, USA., Alvarez C; Department of Pharmacy Practice, Texas Tech University Health Sciences Center School of Pharmacy, Abilene, TX, USA., Gabizon AA; Oncology Institute, Shaare Zedek Medical Center and Hebrew University-Faculty of Medicine, Jerusalem, Israel.; Levco Pharmaceuticals Ltd., Jerusalem, Israel., La-Beck NM; Department of Immunotherapeutics and Biotechnology, Texas Tech University Health Sciences Center School of Pharmacy, Abilene, TX, USA.; Department of Pharmacy Practice, Texas Tech University Health Sciences Center School of Pharmacy, Abilene, TX, USA.

المصدر: Nanotheranostics [Nanotheranostics] 2022 Sep 01; Vol. 6 (4), pp. 451-464. Date of Electronic Publication: 2022 Sep 01 (Print Publication: 2022).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Ivyspring International Publishers Country of Publication: Australia NLM ID: 101698994 Publication Model: eCollection Cited Medium: Internet ISSN: 2206-7418 (Electronic) Linking ISSN: 22067418 NLM ISO Abbreviation: Nanotheranostics Subsets: MEDLINE

مواضيع طبية MeSH: Fibrosarcoma*/drug therapy , Liposomes*, Alendronate/pharmacology ; Animals ; Disease Models, Animal ; Doxorubicin/analogs & derivatives ; Mice ; Mice, Inbred BALB C ; Polyethylene Glycols ; Tissue Distribution ; Tumor Microenvironment

المؤلفون: Anderson TS; Departments of Immunotherapeutics and Biotechnology., Wooster AL; Departments of Immunotherapeutics and Biotechnology., La-Beck NM; Departments of Immunotherapeutics and Biotechnology.; Pharmacy Practice, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, Texas, USA., Saha D; Departments of Immunotherapeutics and Biotechnology., Lowe DB; Departments of Immunotherapeutics and Biotechnology.

المصدر: Melanoma research [Melanoma Res] 2021 Feb 01; Vol. 31 (1), pp. 1-17.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9109623 Publication Model: Print Cited Medium: Internet ISSN: 1473-5636 (Electronic) Linking ISSN: 09608931 NLM ISO Abbreviation: Melanoma Res Subsets: MEDLINE

مواضيع طبية MeSH: Immunoconjugates/*therapeutic use , Melanoma/*drug therapy, Humans ; Immunoconjugates/pharmacology

المؤلفون: La-Beck NM; Department of Immunotherapeutics and Biotechnology, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, TX, United States.; Department of Pharmacy Practice, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, TX, United States., Islam MR; Department of Immunotherapeutics and Biotechnology, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, TX, United States., Markiewski MM; Department of Immunotherapeutics and Biotechnology, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, TX, United States.

المصدر: Frontiers in immunology [Front Immunol] 2021 Jan 08; Vol. 11, pp. 603039. Date of Electronic Publication: 2021 Jan 08 (Print Publication: 2020).

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Review

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Nanomedicine*, Antineoplastic Agents/*adverse effects , Complement Activation/*drug effects , Drug Carriers/*adverse effects , Nanoparticles/*adverse effects , Neoplasms/*drug therapy, Animals ; Antineoplastic Agents/chemistry ; Drug Compounding ; Humans ; Neoplasms/immunology ; Neoplasms/metabolism ; Neoplasms/pathology ; Tumor Microenvironment

المؤلفون: La-Beck NM; Department of Immunotherapeutics and Biotechnology, Texas Tech University Health Sciences Center, Jerry H. Hodge School of Pharmacy, 1718 Pine St, Abilene, TX 79601, USA; Department of Pharmacy Practice, Texas Tech University Health Sciences Center, Jerry H. Hodge School of Pharmacy, 1718 Pin. St, Abilene, TX 79601, USA. Electronic address: irene.la-beck@ttuhsc.edu., Liu X; Department of Pharmacological and Pharmaceutical Sciences, University of Houston, College of Pharmacy, 4849 Calhoun Road, Houston, TX 77204, USA., Shmeeda H; Center of Nano-oncology, Shaare Zedek Medical Center, Jerusalem, Israel. Electronic address: hilary@szmc.org.il., Shudde C; Department of Immunotherapeutics and Biotechnology, Texas Tech University Health Sciences Center, Jerry H. Hodge School of Pharmacy, 1718 Pine St, Abilene, TX 79601, USA. Electronic address: ces14a@acu.edu., Gabizon AA; Center of Nano-oncology, Shaare Zedek Medical Center and Hebrew University-School of Medicine, POB 3235, Jerusalem, 91031, Israel. Electronic address: agabizon@szmc.org.il.

المصدر: Seminars in cancer biology [Semin Cancer Biol] 2021 Jan; Vol. 68, pp. 175-185. Date of Electronic Publication: 2019 Dec 23.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Academic Press Country of Publication: England NLM ID: 9010218 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-3650 (Electronic) Linking ISSN: 1044579X NLM ISO Abbreviation: Semin Cancer Biol Subsets: MEDLINE

مواضيع طبية MeSH: Drug Discovery*, Antineoplastic Agents/*therapeutic use , Diphosphonates/*therapeutic use , Drug Compounding/*methods , Drug Repositioning/*methods , Liposomes/*administration & dosage , Neoplasms/*drug therapy, Animals ; Diphosphonates/chemistry ; Humans ; Liposomes/chemistry